Re: Zenith share issue

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jbuffett62

Rank: Treasurer [?]

Points: 455 [?]

Votes: 13 Score: 2.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith share issue

posted on Nov 15, 2017 11:07AM

Please share details as to why you feel this way. Any idea of what a buyout of this sort would render as a pps?